| For: | Ferrusquía J, Pérez-Martínez I, Gómez de la Torre R, Fernández-Almira ML, de Francisco R, Rodrigo L, Riestra S. Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity. World J Gastroenterol 2015; 21(13): 4069-4077 [PMID: 25852295 DOI: 10.3748/wjg.v21.i13.4069] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i13/4069.htm |
| Number | Citing Articles |
| 1 |
Izaskun Pizarro Carbajo, Alfonso Gutiérrez Macías, Markel Cea Gómez, Itxaso Lombide Aguirre. Fever induced by mesalazine. Gastroenterología y Hepatología (English Edition) 2018; 41(4) doi: 10.1016/j.gastre.2018.04.006
|
| 2 |
Nicole Tejeda Taveras , Arlenys Rivera Martinez, Ram Kumar, Amna Jamil, Besham Kumar. Pulmonary Manifestations of Inflammatory Bowel Disease. Cureus 2021; doi: 10.7759/cureus.14216
|
| 3 |
Ferdinando D’Amico, Ernesto Fasulo, Vipul Jairath, Kristine Paridaens, Laurent Peyrin-Biroulet, Silvio Danese. Management and treatment optimization of patients with mild to moderate ulcerative colitis. Expert Review of Clinical Immunology 2024; 20(3) doi: 10.1080/1744666X.2023.2292768
|
| 4 |
Qian Xie, Hongyan Li, Rong Ma, Mihong Ren, Yong Li, Jinxiu Li, Hai Chen, Zhuoping Chen, Daoyin Gong, Jian Wang. Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model. Phytomedicine 2022; 97 doi: 10.1016/j.phymed.2022.153927
|
| 5 |
|
| 6 |
Marianna M. Henry, Terry L. Noah. Kendig's Disorders of the Respiratory Tract in Children. 2019; doi: 10.1016/B978-0-323-44887-1.00059-6
|
| 7 |
Jina Yeo, Hyun Sun Woo, Sang Min Lee, Yoon Jae Kim, Kwang An Kwon, Dong Kyun Park, Jung Ho Kim, Kyoung Oh Kim, Jun-Won Chung. Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide. Intestinal Research 2017; 15(4) doi: 10.5217/ir.2017.15.4.529
|
| 8 |
Takuro Sato, Manabu Tagawa, Isho Izumi, Takumi Kiwamoto, Ryo Sumazaki. Mesalazine‐induced lung injury in a child; the value of bronchoscopy. Pediatrics International 2021; 63(11) doi: 10.1111/ped.14640
|
| 9 |
Toshiaki Inazaki, Kenichiro Takeda, Mana Iwasaki, Hiroki Tajima, Yu Shionoya, Ryutaro Hirama, Shun Sato, Akira Naito, Takeshi Kawasaki, Jun Ikari, Satoko Kageyama, Jun‐ichiro Ikeda, Takuji Suzuki. Rapid Onset of Mesalazine‐Induced Eosinophilic Pneumonia Manifesting 7 Days After Initiation: A Case Report. Respirology Case Reports 2026; 14(9) doi: 10.1002/rcr2.70758
|
| 10 |
Jiaxi Chen, Mengyue Pan, Jingjie Wang, Mengling Zhang, Mingmei Feng, Xiaoming Chai, Qi Zhang, Yang Sun. Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota. Toxicology and Applied Pharmacology 2023; 467 doi: 10.1016/j.taap.2023.116494
|
| 11 |
P. Sehgal, J.‐F. Colombel, A. Aboubakr, N. Narula. Systematic review: safety of mesalazine in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2018; 47(12) doi: 10.1111/apt.14688
|
| 12 |
Irfan A. Rather, Vivek K. Bajpai, Lew L. Ching, Rajib Majumder, Gyeong-Jun Nam, Nagaraju Indugu, Prashant Singh, Sanjay Kumar, Nahid H. Hajrah, Jamal S.M. Sabir, Majid Rasool Kamli, Yong-Ha Park. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi Journal of Biological Sciences 2020; 27(1) doi: 10.1016/j.sjbs.2019.09.004
|
| 13 |
Nithiyanandan Ravi, Bala Vigneshwar. When the Cure Turns Into a Culprit: Mesalamine and the Eosinophilic Lung. Cureus 2026; doi: 10.7759/cureus.116143
|
| 14 |
Philippe Camus, Thomas V. Colby. Pulmonary Manifestations of Systemic Diseases. 2019; doi: 10.1183/2312508X.10015019
|
| 15 |
Izaskun Pizarro Carbajo, Alfonso Gutiérrez Macías, Markel Cea Gómez, Itxaso Lombide Aguirre. Fiebre por mesalazina. Gastroenterología y Hepatología 2018; 41(4) doi: 10.1016/j.gastrohep.2017.03.009
|
| 16 |
Ahtshamullah Chaudhry, Jawad Noor, Ghulam Fatima, Saima Batool, Riwad Noor. Mesalamine - A Revered Drug for Inflammatory Bowel Disease With Detrimental Effects on the Lung and Heart. Cureus 2023; doi: 10.7759/cureus.43567
|
| 17 |
Andrei Tudor Cernomaz, Gabriela Bordeianu, Cristina Terinte, Cristina Maria Gavrilescu. Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient – a putative adverse reaction to mesalazine: A case report and review of literature. World Journal of Clinical Cases 2020; 8(18): 4162-4168 doi: 10.12998/wjcc.v8.i18.4162
|
| 18 |
G. N. Yankinа, L. V. Gorlenko, E. V. Loshkova, E. I. Kondratyeva, E. Yu. Tuteva, A. A. Terenteva, V. A. Zhelev, E. V. Mikhalev, T. A. Shemyakinа, T. S. Krivonogova, N. A. Ryzhakova, E. V. Romanova. Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis. Bulletin of Siberian Medicine 2019; 18(3) doi: 10.20538/1682-0363-2019-3-245-257
|
| 19 |
Feng Zhou, Guo Dong Zhang, Yang Tan, Shi An Hu, Qun Tang, Gang Pei. NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231176889
|